Conference item icon

Conference item

Reduction in fracture rates with Denosumab compared to Alendronate in treatment naïve patients: a propensity-matched ‘real world’ cohort and instrumental variable analysis.

Abstract:
To compare the risk of hip and all osteoporotic fracture/s observed amongst treatment naïve users of subcutaneous denosumab and oral alendronate.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s00198-017-3945-z

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
Publisher:
Springer
Host title:
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017)
Journal:
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017) More from this journal
Publication date:
2017-07-24
Acceptance date:
2017-02-01
DOI:
Pubs id:
pubs:709984
UUID:
uuid:d045ec21-8cbe-4fd0-9152-d7b5ab016262
Local pid:
pubs:709984
Source identifiers:
709984
Deposit date:
2017-08-30

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP